Archive: 23/09/2014

XenOPAT, mouse models for personalized cancer treatment

On September 8th, the company XenOPAT SL, a spin-off of the Institute of Biomedical Research (IDIBELL) and the Catalan Institute of Oncology (ICO) was established with the aim of bringing the company the latest scientific ...

page 6 from 11